ClinicalTrials.gov
public full text
Public Domain
Selective Activation of the Adrenomedullin Receptors in Migraine
Adrenomedullin is a neuropeptide implicated in the pathogenesis of migraine. This study investigates whether its administration, after pre-treatment with erenumab (a CGRP-receptor blocking monoclonal antibody), can trigger migraine attacks in individuals with migraine without aura.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies#831363
- The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.#871860
- Tear Biomarkers for Migraine#870467
- Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine#1009492
- MicroRNA Profile and Erenumab Treatment#881092
Record · ID 1093125
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive